Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

注射用盐酸头孢甲肟 - NMPA Drug Approval Details

Approvals/NMPA/Cefmenoxime Hydrochloride for Injection

Approved

化学药品

Cefmenoxime Hydrochloride for Injection

吉林省辉南长龙生化药业股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 10, 2020
Approval ID: 7Leaf55bCtk
Company: 吉林省辉南长龙生化药业股份有限公司
Type: 化学药品

Approval Details

Approval Id: 7Leaf55bCtk
Approval Number: 国药准字H20120116
Generic Name: 注射用盐酸头孢甲肟
Generic Name En: Cefmenoxime Hydrochloride for Injection
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 0.5g(以C16H17N9O5S3计)
Reg Date: 2020-12-10
Company Name: 吉林省辉南长龙生化药业股份有限公司
Production Company Name: 吉林省辉南长龙生化药业股份有限公司
Production Company Address: 辉南经济开发区医药产业园
Company Detail Path: /organization/jilin-changlong
Production Company Detail Path: /organization/jilin-changlong

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 10, 2020

Approval ID

7Leaf55bCtk

Type

化学药品

Back to NMPA Approvals